Protalix Restates Stock Incentive Plan
Protalix BioTherapeutics filed an 8-K to amend and restate its 2006 Stock Incentive Plan, effective June 25, 2026, to provide updated rewards for employees and directors.
View filing at SEC.gov →2 most recent filings and news items mentioning PLX. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/PLX/news?limit=20"
Pull PLX filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayProtalix BioTherapeutics filed an 8-K to amend and restate its 2006 Stock Incentive Plan, effective June 25, 2026, to provide updated rewards for employees and directors.
View filing at SEC.gov →Protalix BioTherapeutics released a corporate presentation dated May 2026 outlining its rare disease treatment pipeline and Elfabrio commercialization plans. The filing includes forward-looking statements regarding cash runway and product commercialization, with risks related to
View filing at SEC.gov →